Perinatal Exposure To Household And Environmental Toxins And The Risk Of Asthma And Allergic Disease Up To 25 Years
Funder
National Health and Medical Research Council
Funding Amount
$291,078.00
Summary
Perinatal exposure to household and environmental toxins may increase asthma and allergic disease risk. Adverse exposures in this critical developmental window may have a marked and prolonged effect on health. A birth cohort of high-allergy risk children will be used to investigate the effect of common chemical exposures on the risk of asthma and allergic disease up to 25 years. This evidence could be used to inform guidelines on common household chemical exposures
The Role Of Bisphenol A In The Development Of Chronic Disease
Funder
National Health and Medical Research Council
Funding Amount
$397,549.00
Summary
There is accumulating evidence to suggest that the environment we live in may be important in the development of chronic disease. This project examines a key environmental toxin Bisphenol A (BPA) and explores the role it has in the development of diabetes, obesity and cardiovascular disease (CVD). In this project, we will explore whether there is an independent relationship between BPA and the development of diabetes, CVD and obesity in humans in a prospective setting.
What Are The Clinical Predictors And Risk Factors For Impaired Child Growth And Development? Following Up The Ha Nam Cohort From Birth To 3 Years
Funder
National Health and Medical Research Council
Funding Amount
$1,189,570.00
Summary
Stunting affects about one third of children under five in developing countries and is a measure of chronic undernutrition. This project will identify pre and postnatal risk factors for impaired child growth and development by monitoring a cohort of infants in Vietnam to three years of age, and developing a predictive algorithm for early detection of those at risk of stunting. Effective preventative measures would improve child health, and prevent a huge burden of disease.
Optimising Severe Malaria Treatment Using Pharmacokinetic-pharmacodynamic Modeling
Funder
National Health and Medical Research Council
Funding Amount
$218,490.00
Summary
Every year, severe malaria kills up to 800,000 people worldwide. To prevent death, a patient must be treated promptly and effectively. Children and adults vary in terms of their response to a malaria drug, and therefore may require a different dosing regimen. We will perform a rigorous analytical assessment of antimalarial drug concentration and efficacy data to determine dosing regimens. This will improve the treatment of severe malaria, and thereby, reduce malaria-related mortality.